Vascular invasion within the tumor and high expression of CUB domain-containing protein (CDCP1) and low levels of insulin-like growth factor binding protein (IGFBP5 and IGFBP7) in the bloodstream have been reported as risk factors for lymph node recurrence [27,28,29]. Here, SPADH is linked to neoplasm.